维普中文期刊产品整合服务
61篇 您的检索式:作者名="LEHTINEN M J"
    题名 作者 年代 出处 被引量
1Initial steps of aerosol growth 显示文摘Kulmala M Laakso L Lehtinen K E J 2004Atmospheric Chemistry and Physics2004,4,1112:1
2Phylogeny of the Fennoscandian cervid strainof Echinococcus granulosus显示文摘Lavikainen A Lehtinen M J Agren E 2005Bulletin of the Scandinavian Baltic Society for Parasitology2005,14,:1
3A mesh- less hierarchical representation for light transport显示文摘Lehtinen J Zwicker M Turquin E 2008ACM Transactions on Graphics2008,27,3:1
4Preventive human papillomavims vaccination显示文摘Lehtinen M Dillner J 2002Sex Transm Infect2002,78,1:1
5Preventive human papillomavirus vaccination显示文摘Lehtinen M Dillner J 2002Sex Transm Infect2002,78,1:1
6Overall efficacy of HPV--16/18 AS04--adjuvanted vaccine a- gainst grade 3 or greater cervical intraepithelial neopla- sia 4- year end--of--study analysis of the random- ised, double-- blind PATRICIA trial显示文摘Lehtinen M Paavonen J Wheeler CM 2012Lancet Oncol2012,13,1:1
7Proximal humeral fractures:regional differences in bone mineral density of the humeral head affect the fixation strength of cancellous screws显示文摘Tingart M J Lehtinen J Zurakowski D 2006J Shoulder Elbow Surg2006,15,5:1
8Fine-particle emissions of energy production in Finland 显示文摘Ohlstrtim M O Lehtinen K E J Moisio M 2000Atmospheric Environment2000,34,22:1
9Mitochondrial DNA data reveal cryptic species within Taenia krabbei显示文摘Lavikainen A Haukisalmi V Lehtinen M J 0,,02:1
10Molecular genetic characterization of the fen- noscandian cervid strain, a new genotypic group (G10) of Echinococcus granulosus 显示文摘LAVIKAINEN A LEHTINEN M J MERI T 2003Parasitolo- gy2003,127,3:1
11Efficacy of preventive human papillo mavirus vac-cination显示文摘Lehtinen M Paavonen J 2001Int J STD AIDS2001,12,12:1
12Effect of intracheal lignocamine, halothane and thipentonal on changes in plasma β-endorphine in response to tracheal intubatioin显示文摘Lehtinen A M Hovorka J leppaluoto J 1994Br J Anesth1994,56,:1
13Fine-particle emissions of energy production in finland显示文摘Ohlstrom M O Lehtinen K E J Moisio M 2000Atmospheric Environment2000,34,22:1
14Overall efficacy of HPV- 16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial 显示文摘Lehtinen M Paavonen J Wheeler CM 2012Lancet Oncol2012,13,1:1
15Proximal humeral fracture: regional differences in bone mineral density of the humeral head affect the fixation strength of cancellous screws 显示文摘TINGART M J LEHTINEN J ZURAKOWSKI D 2006J Shoulder Elbow surg2006,5,:1
16Clinical trials of human papillomavirus vac- cines and beyond显示文摘Lehtinen M Dillner J 2013Nat Rev Clin Oncol2013,10,7:1
17A phylogeny of members of the family Taeniidae based on the mitochondrial cox1 and nadl gene data显示文摘Lavikainen A Haukisalmi V Lehtinen M J 2008Par asitology2008,135,12:1
18人乳头瘤病毒16/18型AS04佐剂疫苗预防肿瘤基因型HPV引起的宫颈感染和癌前病变的效应(PATRICIA):一项在年轻女性中进行的双盲、随机研究的最终分析显示文摘背景在年轻成人中进行的Ⅲ期随机、双盲对照PATRICIA试验(PApilloma TRial)的事件驱动期中分析显示,人乳头瘤病毒(HPV)16/18AS04佐剂疫苗具有免疫原性,且总体耐受性良好,对HPV16或HPV18感染及相关的癌前病变具有预防效应。本文作者旨在评估最终事件驱动分析中的疫苗效应。方法将在基线、1个月和6个月接种疫苗的15~25岁女性分类为符合方案的效应队列(ATP-E队列;疫苗组8093例,对照组8069例)、总接种队列(TVC;包括至少接种1剂疫苗的所有女性,而不考虑其基线HPV状态;代表普遍的年轻女性人群,包括性活跃者;疫苗组9319例,对照组9325例)和TVC-naive(无证据表明基线时存在肿瘤基因型HPV感染;代表无性行为女性;疫苗组5822例,对照组5819例)。主要终点是。在基线时血清和DNA均为阴性且在6个月时为相应类型(ATP-E队列)的女性中,评估疫苗对HPV16或HPV18相关性宫颈上皮内瘤变≥2级(CIN2+)的预防效应。该试验在ClinicalTrial.gov上的注册编码为NCT00122681.结果第3剂疫苗接种后平均随访34.9个月(s=6.4)。在主要分析中疫苗对HPV16/18相关性CIN2+的预防效应为92.9%(96.1%CI79.9%~98.3%),在对可能因多种肿瘤基因型HPV引起的病变(ATP-E队列)的分析中,其预防效应为98.1%(96.1%CI88.4%~100%)。不考虑病变HPVDNA时,疫苗对CIN2+的预防效应在TVC中为30.4%(96.1%CI16.4%~42.1%),在TVC-naive中为70.2%(96.1%CI54.7%~80.9%);而对CIN3+的相应效应在TVC中为33.4%(96.1%CI9.1%~51.5%).在TVC-naive中为87.0%(96.1%CI54.9%~97.7%).在预防12种非疫苗肿瘤基因型HPv相关性CIN2+的效应为54.0%(96.1%CI34.0%~68.4%:ATP-E队列)。在TVC中可见对HPV31、33和45相关性CIN2+的个体交叉保护效应。结论HPV16/18 AS04佐剂疫苗表现出对HPV16/18和非疫苗肿瘤基因型HPV相关性CIN2+较强的预防效应,而要获得整体预防效应就需要在更广泛的人群中进行大面积强化免疫计划。基金 葛兰素史克。J Paavonen P Naud J Salmeron C M Wheeler S-N Chow D Apter H Kitchener X Castellsague J C Teixeira S R Skinner J Hedrick U Jaisamrarn G Limson S Garland A Szarewski B Romanowski F Y Aoki T F Schwarz W A J Poppe F X Bosch D Jenkins K Hardt T Zahaf D Descamps F Struyf M Lehtinen G Dubin 周彩虹(译) 2009世界临床医学2009,,12:1
19Overall efficacy of HPV-16/18 AS04-adju- ranted vaccine against grade 3 or greater cervical intraepithelial neoplasia : 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial 显示文摘Lehtinen M Paavonen J Wheeler CM et at 2012The lancet oncology2012,13,1:1
20Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial 显示文摘Lehtinen M Paavonen J Wheeler CM 2012Lancet On- col2012,13,1:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费